BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12656992)

  • 41. The expression of plasminogen activator system in a rat model of periodontal wound healing.
    Xiao Y; Li H; Bunn C; Bartold PM
    J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gingival crevicular fluid can degrade Emdogain and inhibit Emdogain-induced proliferation of periodontal ligament fibroblasts.
    Laaksonen M; Salo T; Vardar-Sengul S; Atilla G; Saygan BH; Simmer JP; Baylas H; Sorsa T
    J Periodontal Res; 2010 Jun; 45(3):353-60. PubMed ID: 19909398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease.
    Masada MP; Persson R; Kenney JS; Lee SW; Page RC; Allison AC
    J Periodontal Res; 1990 May; 25(3):156-63. PubMed ID: 2141875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measurement of proteinase activity in gingival crevicular fluid following periodontal therapy.
    Zahradnik RT
    Adv Dent Res; 1998 Nov; 12(2):40-2. PubMed ID: 9972120
    [No Abstract]   [Full Text] [Related]  

  • 45. Glycosaminoglycans and periodontal disease: analysis of GCF by safranin O.
    Giannobile WV; Riviere GR; Gorski JP; Tira DE; Cobb CM
    J Periodontol; 1993 Mar; 64(3):186-90. PubMed ID: 8463940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease.
    Skaleric U; Gaspirc B; McCartney-Francis N; Masera A; Wahl SM
    Infect Immun; 2006 Dec; 74(12):7010-3. PubMed ID: 17015454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Relationship between periodontal disease and gingival fluid glucose in diabetic patients].
    Cárdenas Chagoya J; Franco Coops S
    Pract Odontol; 1988 Apr; 9(4):31-2, 34-5, 37-9. PubMed ID: 3075755
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection of tumor necrosis factor in gingival crevicular fluid.
    Lee JM; Turner DW
    Northwest Dent Res; 1992; 3(2):19-24. PubMed ID: 1285953
    [No Abstract]   [Full Text] [Related]  

  • 49. Biochemical markers of periodontal tissue destruction.
    Embery G; Last KS
    Dent Update; 1989 May; 16(4):167-72. PubMed ID: 2699877
    [No Abstract]   [Full Text] [Related]  

  • 50. Smoking and gingivitis: focus on inducible nitric oxide synthase, nitric oxide and basic fibroblast growth factor.
    Özdemir B; Özmeric N; Elgün S; Barış E
    J Periodontal Res; 2016 Oct; 51(5):596-603. PubMed ID: 26667067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The accuracy of clinical parameters in detecting periodontal disease activity.
    Ryan RJ
    J Am Dent Assoc; 1985 Nov; 111(5):753-60. PubMed ID: 3905909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gingival crevicular fluid and plasma levels of neuropeptide Substance-P in periodontal health, disease and after nonsurgical therapy.
    Pradeep AR; Raj S; Aruna G; Chowdhry S
    J Periodontal Res; 2009 Apr; 44(2):232-7. PubMed ID: 18973530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Measurement of sulcus fluid as a diagnostic measure in periodontal diseases. (I). Presence, composition and measurement methods of sulcus fluid].
    Topoll H; Lange DE
    Quintessenz; 1980 May; 31(5):89-93. PubMed ID: 7043539
    [No Abstract]   [Full Text] [Related]  

  • 54. Gingival crevicular fluid transforming growth factor-beta1 in several forms of periodontal disease.
    Gürkan A; Emingil G; Cinarcik S; Berdeli A
    Arch Oral Biol; 2006 Oct; 51(10):906-12. PubMed ID: 16787634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Crevicular fluid: active site marker].
    Margiotta V; Campofiorito G
    Stomatol Mediterr; 1990; 10(2):83-104. PubMed ID: 2171149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of periodontal therapy on gingival crevicular fluid matrix metalloproteinase-8, interleukin-6 and prostaglandin E2 levels in patients with rheumatoid arthritis.
    Kurgan Ş; Fentoğlu Ö; Önder C; Serdar M; Eser F; Tatakis DN; Günhan M
    J Periodontal Res; 2016 Oct; 51(5):586-95. PubMed ID: 26575440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in TGF-beta 1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs.
    Skaleric U; Kramar B; Petelin M; Pavlica Z; Wahl SM
    Eur J Oral Sci; 1997 Apr; 105(2):136-42. PubMed ID: 9151066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acceleration of purine degradation by periodontal diseases.
    Barnes VM; Teles R; Trivedi HM; Devizio W; Xu T; Mitchell MW; Milburn MV; Guo L
    J Dent Res; 2009 Sep; 88(9):851-5. PubMed ID: 19767584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of periostin levels in serum and gingival crevicular fluid of patients with periodontal disease.
    Balli U; Keles ZP; Avci B; Guler S; Cetinkaya BO; Keles GC
    J Periodontal Res; 2015 Dec; 50(6):707-13. PubMed ID: 25529858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Protease inhibitors in gingival crevicular fluid and serum of patients with periodontal disease].
    Osada Y
    Nihon Shishubyo Gakkai Kaishi; 1983 Mar; 25(1):66-79. PubMed ID: 6193210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.